Jingjing Pan

Mechanistic study of lncRNA UCA1 promoting growth and cisplatin resistance in lung adenocarcinoma

Yumin Wang, Kate Huang, Jie Chen, 2021, Cancer Cell International.

Characteristics of Pyroptosis-Related Subtypes and Novel Scoring Tool for the Prognosis and Chemotherapy Response in Acute Myeloid Leukemia

Changhong Li, Jingjing Pan, Yin Jiang, 2022, Frontiers in Oncology.

Integrative analyses identify HIF-1α as a potential protective role with immune cell infiltration in adamantinomatous craniopharyngioma

Fuyou Guo, Di Xu, Jingjing Pan, 2022, Frontiers in Immunology.

DLGAP1-AS2 promotes human colorectal cancer progression through trans-activation of Myc

Xiaobing Guo, Wan-Hai Wang, Chunfeng Ren, 2022, Mammalian Genome.

Characterization of Pyroptosis-Related Subtypes via RNA-Seq and ScRNA-Seq to Predict Chemo-Immunotherapy Response in Triple-Negative Breast Cancer

Jingjing Pan, Yin Jiang, Zhenlin Jin, 2022, Frontiers in Genetics.

Characteristics of the Immune Cell Infiltration Landscape in Gastric Cancer to Assistant Immunotherapy

Jingjing Pan, Yin Jiang, Zhenlin Jin, 2022, Frontiers in Genetics.

Effects of Erlotinib after Acquired Resistance to Gefitinib in Advanced Non-small-cell Lung Cancer

Jifeng Feng, M. Shi, Jingjing Pan, 2012, 2012 International Conference on Biomedical Engineering and Biotechnology.

Prognostic characterization of immune molecular subtypes in non-small cell lung cancer to immunotherapy

Jingjing Pan, Jing Luo, Chenlu Li, 2021, BMC Pulmonary Medicine.

Characteristics of Adenosine-to-Inosine RNA editing-based subtypes and novel risk score for the prognosis and drug sensitivity in stomach adenocarcinoma

Tianjie Li, Jingjing Pan, Xinye Qian, 2022, Frontiers in Cell and Developmental Biology.

Development and validation of an in-hospital mortality risk prediction model for patients with severe community-acquired pneumonia in the intensive care unit

Zhi Geng, Jingjing Pan, M. Shao, 2023, BMC Pulmonary Medicine.